Neurocrine Biosciences Inc

NAS:NBIXHealthcareNASDAQ:NBINASDAQ:NQUSMG

$136.98+0.94%At closeAt close · Tue 20 Oct · ≈ AED 503.06 · Market cap $13.92B · Next earnings Tue 27 Oct · Extended $137.56 +0.42%

USD billions	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025	YoY
Cash & cash equivalents	0.2	0.3	0.3	0.3	0.2	0.7	+206.0%
Cash & short-term investments	0.8	0.7	1.0	1.0	1.1	1.5	+37.6%
Receivables	0.2	0.2	0.4	0.4	0.5	0.7	+43.4%
Inventory	0.0	0.0	0.0	0.0	0.1	0.1	+20.2%
Total current assets	1.0	1.0	1.5	1.6	1.7	2.5	+46.3%
Property, plant & equipment	0.1	0.2	0.1	0.3	0.6	0.5	−7.9%
Goodwill & intangibles	0.0	0.0	0.0	0.0	0.0	0.0	−100.0%
Long-term investments	0.3	0.6	0.4	0.8	0.9	1.2	+37.0%
Total assets	1.7	2.1	2.4	3.3	3.7	4.6	+24.5%
Payables	0.0	0.1	0.1	0.1	0.1	0.1	−4.6%
Short-term debt	0.0	0.0	0.2	0.2	0.0	0.0	—
Total current liabilities	0.2	0.2	0.5	0.7	0.5	0.7	+46.4%
Long-term debt	0.3	0.3	0.0	0.0	0.0	0.0	—
Total debt	0.4	0.4	0.3	0.4	0.5	0.4	−8.7%
Net debt	0.2	0.1	0.0	0.2	0.2	(0.3)	−234.0%
Deferred revenue	0.0	0.0	0.0	0.0	0.0	0.0	—
Total liabilities	0.6	0.7	0.7	1.0	1.1	1.4	+22.1%
Total equity	1.1	1.4	1.7	2.2	2.6	3.3	+25.6%
Retained earnings	(0.7)	(0.6)	(0.4)	(0.2)	0.0	0.4	+1433.2%

USD billionsUpdated Fri 31 Jul ·

ⓘ

Amounts are shown in the stated units; per-share amounts and shares are unscaled. Negative amounts are in brackets.